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Introduction
Because of its central role in initiating homologous recombina-
tion repair (HRR), DNA strand resection at DNA double-strand 
breaks (DSBs) is regulated during the cell cycle, thus restricting 
HRR to S and G2. In yeasts, Cdk activity plays a major role in 
controlling DNA strand resection (Wohlbold and Fisher, 2009). 
In part, this is controlled through Cdk-mediated phosphoryla-
tion of Sae2, a protein required to initiate the resection process 
(Huertas et al., 2008). Vertebrate cells express an orthologue of 
Sae2, CtIP (C-terminal interacting protein), which is also cru-
cial for DSB resection (Sartori et al., 2007). Strand resection is 
also cell cycle regulated in vertebrate cells, and evidence sug-
gests that Cdks may regulate this process at least in part via di-
rect phosphorylation of CtIP in a manner analogous to yeast 
(Huertas and Jackson, 2009; Yun and Hiom, 2009). However, 
whether this is the only mechanism underlying cell cycle regu-
lation of DSB resection in vertebrates is unclear.
In addition to forming a substrate for HRR, tracts of 
single-stranded DNA play a key role in triggering aspects 
of the DNA damage checkpoint response by recruiting and   
activating the PIKK (PI3-kinase–like kinase) ATR (ataxia tel-
angiectasia  and  Rad3  related;  Cimprich  and  Cortez,  2008). 
Unlike the related PIKK ATM (ataxia telangiectasia mutated), 
which can be activated simply through association with DSBs 
(Harrison and Haber, 2006), ATR is activated through recruit-
ment to regions of single-stranded DNA in association with 
its partner protein, ATRIP (ATR-interacting protein; Cimprich   
and Cortez, 2008). Once activated, ATR and ATM selectively 
phosphorylate and activate two downstream checkpoint ef-
fector kinases, Chk1 and Chk2 (Harrison and Haber, 2006). 
Phosphorylation of Chk1 by ATR at serine 345 (S345) within 
the C-terminal regulatory domain in particular is essential for 
both the DNA damage and replication checkpoint responses in 
vertebrates (Walker et al., 2009).
Interestingly,  recent  data  indicate  that  phosphorylation 
and activation of Chk1 by ATR in response to DSBs is also cell 
cycle regulated. Thus, in human T24 cultures released from 
density arrest, Chk1 was activated in response to irradiation 
only in cells that had reached S and G2 phase (Jazayeri et al., 
2006). Consistent with this, Chk1 was activated most strongly 
U
sing chemical genetics to reversibly inhibit Cdk1, 
we find that cells arrested in late G2 are unable 
to delay mitotic entry after irradiation. Late G2 
cells detect DNA damage lesions and form -H2AX foci 
but fail to activate Chk1. This reflects a lack of DNA   
double-strand break processing because late G2 cells fail   
to recruit RPA (replication protein A), ATR (ataxia telangi-
ectasia and Rad3 related), Rad51, or CtIP (C-terminal 
interacting  protein)  to  sites  of  radiation-induced  dam-
age, events essential for both checkpoint activation and 
initiation of DNA repair by homologous recombination. 
Remarkably, inhibition of Akt/PKB (protein kinase B) 
restores DNA damage processing and Chk1 activation 
after irradiation in late G2. These data demonstrate a 
previously unrecognized role for Akt in cell cycle regula-
tion of DNA repair and checkpoint activation. Because 
Akt/PKB  is  frequently  activated  in  many  tumor  types, 
these findings have important implications for the evolu-
tion and therapy of such cancers.
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arrested in late G2, as indicated by high levels of cyclin B2 and 
Y15-phosphorylated Cdk1 (Fig. S1 A). Thus, loss of checkpoint 
proficiency is a consequence of cell cycle position and not of 
Cdk1 inhibition by itself.
We next used the reversible Cdk1-selective inhibitor,   
RO-3306 (Vassilev et al., 2006), to arrest HCT116 cells in late G2 
phase and then released them with or without prior irradiation. 
As shown in Fig. 1 (D and E), irradiation had no effect on mi-
totic entry after release, despite the formation of prominent   
-H2AX foci in damaged cells. Neither did we observe Chk1 
pS345 phosphorylation in RO-3306–arrested HCT116 cells, al-
though activation was robust in asynchronous cultures (Fig. 1 F). 
Thus, we conclude that loss of DNA damage checkpoint profi-
ciency is a general feature of cells arrested in late G2.
Checkpoint deficiency in late G2 stems 
from lack of DNA damage processing
Chk1  S345  phosphorylation  is  mediated  primarily  by ATR, 
whose activity depends on concentration at stretches of single-
stranded DNA coated with RPA (replication protein A) gener-
ated by DNA strand resection from DSBs. To gain insight into 
the processing of DSBs in late G2, we examined the subcellular 
localization of RPA and ATR.
As  shown  in  Fig.  2  (A  and  B),  irradiation  induced  a 
marked concentration of RPA and ATR in nuclear foci in a ma-
jority of asynchronous Cdk1AS and HCT116 cells; however, 
no chromatin-associated foci were observed in late G2–arrested 
cells. In cells proficient for HRR, RPA is displaced from single-
stranded DNA by Rad51 to initiate homologous recombination. 
Consistent with this, irradiation induced the formation of nu-
merous prominent Rad51 foci in many proliferating Cdk1AS 
and HCT116 cells, which often colocalized with -H2AX (Fig. 2, 
A and B). Strikingly, although -H2AX foci formed in late G2–
arrested Cdk1AS and HCT116 cells, no recruitment of Rad51 
was observed. Collectively, these data indicate that late G2   
cells fail to resect DSBs to generate single-stranded DNA, thus 
leading to failure to recruit or activate ATR or initiate later 
events required for HRR.
To gain insight into possible explanations for this defect, 
we examined the effect of irradiation on the subcellular distri-
bution of CtIP, a key protein involved in DSB strand resection. 
In proliferating Cdk1AS and HCT116 cells, CtIP was observed 
to concentrate in nuclear foci after irradiation, where it partially 
colocalized with RPA; however, this did not occur in irradiated 
late G2 cells (Fig. 2, A and B). Because CtIP is required for 
DNA strand resection at DSBs (Sartori et al., 2007), it seems 
likely that failure to recruit this component to sites of damage 
contributes to the resection defect.
To confirm that the ATR–Chk1 pathway was potentially 
functional in late G2–arrested cells, we expressed a TopBP1-
ER fusion protein that activates ATR in response to tamoxifen   
(Toledo et al., 2008). Tamoxifen activated Chk1 as potently as 
irradiation when added to proliferating Cdk1AS–TopBP1-ER 
cells (Fig. 3 A). Tamoxifen also stimulated Chk1 S345 phos-
phorylation  in  late  G2–arrested  cells,  albeit  more  weakly,   
demonstrating that the ATR–Chk1 pathway remains compe-
tent for activation.
in fractions enriched for S- and G2-phase cells when irradiated 
DT40 cell cultures were fractionated by elutriation (Walker   
et al., 2009). Cell cycle–dependent DSB processing to generate 
single-stranded DNA is likely to play a role in determining this 
pattern of ATR–Chk1 activation (Jazayeri et al., 2006); however, 
it remains possible that other cell cycle phase–specific processes 
could also contribute. Finally, it has been reported that Chk1 
becomes refractory to activation by DNA damage in mitotic 
cells (Shiromizu et al., 2006); however, when this desensitiza-
tion occurs and whether it is imposed via the same regulatory 
processes that operate during interphase are unknown.
Results and discussion
DNA damage fails to activate Chk1 or 
delay mitotic entry in late G2
Chk1 is refractory to activation by DNA damage in mitotic 
cells (Shiromizu et al., 2006); however, when desensitization 
occurs is unclear. To assess checkpoint proficiency in late G2, 
we used a DT40 cell line, Cdk1AS, in which a mutant, analogue-
sensitive (AS) form of Cdk1 replaces the endogenous kinase 
(Hochegger et al., 2007). When exposed to the ATP analogue 
1NM-PP1, Cdk1AS cells accumulated homogenously in G2,   
and  when  the  drug  was  washed  away,  the  great  majority   
rapidly entered mitosis and divided (Fig. 1 A; Hochegger   
et al., 2007). Importantly, the negative regulatory phosphory-
lation  on  tyrosine  15  (Y15),  which  restrains  Cdk1  catalytic   
activity before mitosis and forms the principal target of the 
DNA damage checkpoint, is maintained in 1NM-PP1–arrested 
cells (Hochegger et al., 2007).
Remarkably, when G2-arrested Cdk1AS cells were irradi-
ated (10 Gy) before release, we observed a complete absence of 
G2 checkpoint proficiency (Fig. 1 A). This was unexpected be-
cause asynchronous cultures of Cdk1AS cells arrested in G2   
efficiently after irradiation (unpublished data). Furthermore, 
DNA damage was sensed in the G2-arrested cells because   
irradiation induced prominent -H2AX foci (Fig. 1 B) and nu-
clear recruitment of Mre11, both of which were attenuated by 
treatment with the ATM inhibitor Ku55933 (Fig. S1 B, right). 
These observations indicate that ATM is activated by DNA dam-
age in late G2 cells; however, irradiation-induced mitotic delay in 
DT40 cells has been shown to be dependent on ATR-mediated 
activation of Chk1 (Zachos et al., 2003; Walker et al., 2009). 
Strikingly, although Chk1 S345 phosphorylation could be in-
duced by irradiation of asynchronous cultures, no correspond-
ing activation occurred in G2-arrested cells (Fig. 1 C).
To rule out the possibility that loss of checkpoint profi-
ciency might be an artifact of prolonged 1NM-PP1 exposure, 
elutriated fractions of Cdk1AS cells enriched in G1/early S or 
late S/G2/M cells (Fig. S1 A) were irradiated either immediately 
or after culture for a further 4 h in the presence of 1NM-PP1. 
Although irradiation activated Chk1 only weakly in the G1/
early S population immediately after fractionation, activation 
was much stronger after 4 h, when most cells (95%) had entered 
S phase (Fig. S1 A). Conversely, Chk1 was activated strongly 
in the late S/G2/M population immediately after isolation but 
only weakly after 4-h culture in 1NM-PP1, when most cells had 299 Akt regulates DNA damage and checkpoint signaling • Xu et al.
Plk1 kinase is active in G2 and is required for recov-
ery from DNA damage–induced checkpoint arrest (Macůrek   
et al., 2008); however, pretreatment with Plk1 inhibitor did 
not  restore  Chk1  activation  after  irradiation  in  late  G2–
  arrested cells (Fig. 3 B). Because Akt/PKB kinase activity 
has been reported to override DNA damage–induced G2 ar-
rest (Henry et al., 2001; Shtivelman et al., 2002; Nimbalkar 
and Quelle, 2008), we examined the effect of two selective 
Akt inhibitors, Akt-I and Akt1/2-I. Remarkably, pretreatment 
Inhibition of Akt/PKB restores Chk1  
activation and DNA damage processing  
in late G2
1NM-PP1–arrested Cdk1AS cells express high levels of Cdk2 
activity (Hochegger et al., 2007; Bourke et al., 2010), which is 
known to be sufficient to sustain both resection and checkpoint 
activation (Cerqueira et al., 2009). Therefore, we considered 
that some other pathway or kinase active in G2 might actively 
suppress DNA damage processing.
Figure 1.  DNA damage fails to activate Chk1 or mitotic delay in late G2–arrested Cdk1AS or HCT116 cells. (A) Mitotic entry in Cdk1AS cells released from 
1NM-PP1 arrest with or without irradiation. (B) -H2AX staining of 1NM-PP1–arrested Cdk1AS cells before and after release with or without irradiation.   
(C) Western blot of total and pS345 Chk1 in asynchronous (Asy) and 1NM-PP1–arrested Cdk1AS cells 30 min after exposure to 10 Gy ionizing radiation 
(IR) and after release. (D–F) As for A–C using RO-3306–arrested HCT116 colon carcinoma cells. (A and D) Values represent the mean and standard devia-
tion of three independent experiments. Ctrl, control. Bars, 10 µm.JCB • VOLUME 190 • NUMBER 3 • 2010   300
in late G2–arrested HCT116 cells, whereas depletion of Akt1 
had little effect (Fig. S2 B and not depicted).
To determine whether inhibition of Akt could restore DNA 
damage processing in late G2, cells were irradiated with or without 
pretreatment with Akt inhibitor, and the subcellular distribution of 
CtIP, RPA, and Rad51 was visualized. As shown in Fig. 4 (A and B),   
inhibition of Akt restored focal accumulation of CtIP, RPA, and 
Rad51 in late G2–arrested Cdk1AS and HCT116 cells. Nuclear ac-
cumulation of CtIP after damage was also substantially restored in 
RO-3306–arrested HCT116 cells after simultaneous siRNA deple-
tion of Akt1 and Akt2 (Fig. S2 C). Thus, reactivation of Chk1 by 
Akt inhibition in late G2–arrested cells after DNA damage is, at 
least in part, the result of restoration of DNA damage processing.
with  both  inhibitors  reactivated  Chk1  S345  phosphoryla-
tion in G2-arrested Cdk1AS cells after irradiation (Fig. 3 B and   
Fig. S2 A). Akt inhibition alone did not result in DNA dam-
age  because  cells  treated  with  inhibitor  alone  showed  no   
-H2AX foci (Fig. S2 A). Akt inhibition was confirmed using 
an antibody against Akt phosphorylated on serine 473 (S473), 
a modification specific to the active form (Fig. 3 B; Bozulic and 
Hemmings, 2009). Chemical inhibition of Akt also restored   
irradiation-induced Chk1 S345 phosphorylation in RO-3306– 
arrested HCT116 cells (Fig. 3 C and Fig. S2 A). As an alterna-
tive means of inhibiting Akt catalytic activity, we depleted Akt 
isoform expression using siRNA. Interestingly, depletion of 
Akt2 restored irradiation-induced Chk1 S345 phosphorylation 
Figure 2.  Lack of DNA damage processing in late G2–arrested Cdk1AS and HCT116 cells. (A) Subcellular localization of RPA, ATR, Rad51, -H2AX, and 
CtIP in asynchronous (Asy) and 1NM-PP1–arrested Cdk1AS cells with or without prior irradiation (10 Gy). DAPI staining is included in the merged images 
to visualize nuclei. (B) As for A, but using asynchronous or RO-3306–arrested HCT116 cells. IR, ionizing radiation. Bars, 10 µm.301 Akt regulates DNA damage and checkpoint signaling • Xu et al.
resection is remarkable. In addition to loss of checkpoint profi-
ciency, these data predict that proficiency for HRR will also be lost 
late in G2. Consistent with this idea, DNA repair is inefficient in 
late G2–arrested cells, as judged by the persistence of high levels of 
-H2AX 6–8 h after irradiation, when levels have substantially de-
clined in asynchronous controls (Fig. S3 B). Interestingly, a recent 
study demonstrated a link between the dissolution of Rad51 foci 
and mitotic entry (Ayoub et al., 2009). Therefore, one possibility is 
that DNA strand resection may be switched off late in G2 simply to 
terminate recombination in preparation for mitotic entry and chro-
mosome segregation. Because recombination and ATR activation 
are both initiated by single-stranded DNA, this could explain their 
coregulation. However, checkpoint deactivation might also be re-
quired for a normal G2/M transition because recent data have 
shown that Chk1 and Cdk1 interact in a feedback loop that contrib-
utes to timing mitotic entry (Enomoto et al., 2009).
One major question arising from these experiments concerns 
the molecular mechanism or mechanisms by which Akt antago-
nizes DNA damage processing and checkpoint signaling. We pos-
tulate that Akt inhibits the expression or activity of one or more 
factors required for DSB resection, perhaps opposing the positive 
effects of Cdk-mediated phosphorylation (Wohlbold and Fisher, 
2009). Interestingly, Akt activity is strongly cell cycle regulated in 
Cdk1AS cells with very high levels in G1, low levels in S, and 
intermediate levels again in G2 (Fig. S1 A and not depicted). 
The basis of this regulation is not understood; however, similar   
To determine whether augmenting Akt activity could   
suppress Chk1 activation in proliferating cells, we first used   
a  constitutively  active,  oncogenic  form  of Akt  (gag-Akt).   
As shown in Fig. S3 A, proliferating HCT116 cells transfected   
with gag-Akt failed to activate Chk1 efficiently; however, activa-
tion was restored by treatment with Akt inhibitor. Furthermore,   
whereas irradiation induced prominent -H2AX foci in gag-Akt– 
expressing cells, RPA, ATR, and CtIP failed to concentrate in 
nuclear foci, indicating that DNA damage processing was also 
suppressed (Fig. S3 A, right).
Oncogenic activation of Akt frequently results from loss 
of PTEN expression or function (Chalhoub and Baker, 2009).   
To determine how PTEN loss affects DNA damage signaling, 
we took advantage of a PTEN-deficient HCT116 derivative (Lee   
et al., 2004). PTEN
/ HCT116 cells exhibited much higher 
levels of active S473-phosphorylated Akt than either parental 
HCT116 cells or a drug-resistant control (HCT116
NeoR; Fig. 5 A). 
Strikingly, activation of Chk1 S345 phosphorylation after irra-
diation was greatly attenuated in PTEN
/ HCT116 cells com-
pared with controls, and this was associated with weaker nuclear 
recruitment of both RPA and CtIP (Fig. 5 B). Thus, physiologi-
cal activation of Akt as a result of genetic inactivation of PTEN 
also leads to suppression of DNA damage signaling.
The finding that the ATR–Chk1 pathway, and thus DNA 
damage checkpoint proficiency, becomes refractory to activation 
late in G2 before the onset of mitosis because of lack of DSB   
Figure 3.  DNA damage–induced Chk1 S345 
phosphorylation can be restored in late G2–
arrested cells by Akt inhibition. (A) Compari-
son of TopBP1-mediated activation of ATR and 
Chk1 pS345 phosphorylation in asynchronous 
(Asy) and 1NM-PP1–arrested Cdk1AS cells ex-
posed to tamoxifen or irradiation. (B) Western 
blot of asynchronous or G2-arrested Cdk1AS 
cells pretreated with the indicated kinase in-
hibitors  for  1.5  h  plus  or  minus  irradiation. 
(C) Western blot of G2-arrested HCT116 cells 
pretreated with Akt inhibitor for 1.5 h plus or 
minus irradiation. IR, ionizing radiation.JCB • VOLUME 190 • NUMBER 3 • 2010   302
Chk1 activation in proliferating cells and recruitment of RPA, 
ATR,  and  CtIP  to  sites  of  damage  is  consistent  with  this   
possibility. Also consistent is the finding that Akt inhibition 
markedly enhances DNA damage–induced Chk1 activation in 
proliferating cells. This is unlikely to be mediated via direct 
phosphorylation of Chk1 by Akt (Puc et al., 2005) because a 
Chk1 S280A mutant is similarly affected (Fig. S3 C); however, 
further work will be required to determine whether this amplifi-
cation reflects more extensive DNA damage processing after 
Akt inhibition.
Finally, it is pertinent to consider the broader implications 
of these findings. Akt is deregulated in many human tumors 
(Yuan and Cantley, 2008). It has generally been considered 
that Akt deregulation either drives tumor cell proliferation   
fluctuations have been observed in other cell types in which Akt   
activity has also been implicated in regulation of the G2/M transition 
(Shtivelman et al., 2002). Interestingly, the level of Mre11, a factor 
required for strand resection, was markedly reduced in PTEN
/ 
HCT116 cells compared with controls (Fig. 5 A), whereas consti-
tutive Akt activity has been reported to inhibit recombination by 
inducing cytoplasmic sequestration of Rad51 and Brca1 (Plo et al., 
2008). Although suggestive of possible mechanisms, further work 
will be required to identify the target or targets through which Akt 
modulates DNA damage signaling.
A second important question is whether Akt activity also 
modulates DNA damage processing throughout the cell cycle. 
That ectopic expression of a constitutively active, oncogenic 
form of Akt markedly suppresses both DNA damage–induced 
Figure 4.  DNA damage processing can be restored in late G2–arrested Cdk1AS and HCT116 cells by Akt inhibition. (A) Subcellular localization of CtIP, 
RPA, -H2AX, and Rad51 in 1NM-PP1–arrested Cdk1AS cells pretreated with Akt inhibitor for 1.5 h plus or minus irradiation (10 Gy). DAPI staining is 
included in the merged images to visualize nuclei. (B) As for A, but using RO-3306–arrested HCT116 cells. IR, ionizing radiation. Bars, 10 µm.303 Akt regulates DNA damage and checkpoint signaling • Xu et al.
It  is  possible  that  tumors  that  evolve  through  such  a  path 
would exhibit both increased levels of genome instability and 
resistance to genotoxic anticancer therapies. Future work will 
seek to evaluate these possibilities.
Materials and methods
Cell culture, synchronization, siRNA, DNA transfection, and  
chemical inhibitors
Cdk1AS DT40 cells were grown in DME (Invitrogen) containing 10% fetal 
bovine serum, 1% chicken serum, 10
5 M -mercaptoethanol, penicillin, 
and streptomycin at 39.5°C. To synchronize Cdk1AS cells in late G2, 10 µM   
1NM-PP1 was added to the medium for 12–16 h. Wild-type and PTEN- 
deficient HCT116 cells (gift of T. Waldman, Lombardi Comprehensive Can-
cer Center, Georgetown University School of Medicine, Washington, DC; 
directly or enhances cell survival (Manning and Cantley, 2007). 
Our findings suggest an alternative, complementary possibil-
ity, namely that Akt activation may allow cells to evade the 
deleterious consequences of DNA damage. The early stages 
of neoplasia are often associated with spontaneous genotoxic 
stress,  and  the  resulting  DNA  damage  signaling  can  elicit   
tumor-suppressive responses such as cell senescence or apop-
tosis (Bartkova et al., 2006; Di Micco et al., 2006; Toledo   
et al., 2008). Mutations that dampen the cellular response to 
DNA damage signals, such as loss of p53, or attenuate the 
initial generation of such signals, as we propose in this study 
for Akt, would be subject to powerful selection by allowing 
cells to proliferate successfully in the face of such damage.   
Figure 5.  PTEN inactivation suppresses DNA 
damage signaling. (A) Western blot analysis 
of total and pS345 Chk1, pS473 Akt, PTEN, 
Mre11, CtIP, and tubulin expression in paren-
tal HCT116 cells and neomycin-resistant and   
PTEN-deficient derivatives. (B) Subcellular local-
ization  of  RPA,  CtIP,  and  -H2AX  in  paren-
tal  or  PTEN-deficient  HCT116  cells  plus  or 
minus  irradiation  (10  Gy).  DAPI  staining  is 
included  in  the  merged  images  to  visualize   
nuclei. IR, ionizing radiation. Bars, 10 µm.JCB • VOLUME 190 • NUMBER 3 • 2010   304
were obtained from Cell Signaling Technology, whereas monoclonal anti-
body against -tubulin (DM1A) was obtained from Sigma-Aldrich. A poly-
clonal antiserum against avian cyclin B2 was generated by Eurogentec. 
Polyclonal antibodies against pan Akt, pS473 Akt, Akt1, Akt2, and CtIP 
(T16) were purchased from Cell Signaling Technology. Monoclonal anti-
bodies against -H2AX and PTEN were obtained from Millipore and Santa 
Cruz Biotechnology, Inc., respectively.
Online supplemental material
Fig. S1 shows that loss of Chk1 activation is a consequence of cell cycle 
position. Fig. S2 shows that inhibition of Akt restores irradiation-induced 
Chk1 activation in late G2. Fig. S3 shows that constitutively active Akt sup-
presses  Chk1  activation  and  DNA  damage  processing  in  proliferating 
HCT116 cells. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201003004/DC1.
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